Overview
The first FDA-approved treatment for equine protozoal myeloencephalitis (EPM).

  • Ponazuril, the active ingredient, crosses the blood/brain barrier to reach the central nervous system where it kills Sarcocystis neurona
  • Precalibrated oral dosing syringe ensures accurate delivery of each dose
  • Easy to administer correctly; the horse owner can give the full dose each time
Patterson:
07-891-3001
Manufacturer:
126672
Patterson:
07-893-3107
Manufacturer:
126674